A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)

Robert Huddart,Rhian Gabe,Fay H. Cafferty,Philip Pollock,Jeffrey D. White,Jonathan Shamash,Michael Cullen,Sp Stenning

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)

2015

Robert Huddart
Rhian Gabe
Fay H. Cafferty
Philip Pollock
Jeffrey D. White
Jonathan Shamash
Michael Cullen
Sp Stenning

Background Standard chemotherapy for poor-prognosis metastatic nonseminoma has remained bleomycin, etoposide, and cisplatin (BEP) for many years; more effective regimens are required.

Keywords:

Etoposide
Urology
Carboplatin
Vincristine
Cisplatin
Germ cell
Chemotherapy
Induction chemotherapy
Bleomycin
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations